Published in Br Med J on May 10, 1980
Campylobacter enteritis in Denver. West J Med (1982) 1.23
Growth of non-Campylobacter, oxidase-positive bacteria on selective Campylobacter agar. J Clin Microbiol (1982) 0.83
Evolution and comparative genomics of Campylobacter jejuni ST-677 clonal complex. Genome Biol Evol (2014) 0.79
Campylobacter Enteritis. Infection (1982) 0.78
Subdural space Campylobacter infection in a child. CMAJ (1987) 0.75
Attempts to isolate Campylobacter jejuni from various body sites. J Clin Pathol (1983) 0.75
Related vibrio in stools. J Pediatr (1973) 12.85
Campylobacter infections in human beings. J Pediatr (1979) 3.72
Revision of Campylobacter, Helicobacter, and Wolinella taxonomy: emendation of generic descriptions and proposal of Arcobacter gen. nov. Int J Syst Bacteriol (1991) 6.16
Susceptibility of the Bacteroides fragilis group in the United States in 1981. Antimicrob Agents Chemother (1983) 3.83
Characterization of some Actinomyces-like isolates from human clinical specimens: reclassification of Actinomyces suis (Soltys and Spratling) as Actinobaculum suis comb. nov. and description of Actinobaculum schaalii sp. nov. Int J Syst Bacteriol (1997) 2.95
An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med (1995) 2.82
Comparative study of the in vitro antibacterial activity of cefoxitin, cefuroxine, and cephaloridine. Antimicrob Agents Chemother (1976) 2.65
Identification of EF group 22 campylobacters from gastroenteritis cases as Campylobacter concisus. J Clin Microbiol (1989) 2.53
Classification of Alcaligenes faecalis-like isolates from the environment and human clinical samples as Ralstonia gilardii sp. nov. Int J Syst Bacteriol (1999) 2.52
Adhesion of Streptococcus pneumoniae to human pharyngeal epithelial cells in vitro: differences in adhesive capacity among strains isolated from subjects with otitis media, septicemia, or meningitis or from healthy carriers. Infect Immun (1981) 2.33
Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. Rev Infect Dis (1985) 2.26
Taxonomic study of lancefield streptococcal groups C, G, and L (Streptococcus dysgalactiae) and proposal of S. dysgalactiae subsp. equisimilis subsp. nov. Int J Syst Bacteriol (1996) 2.25
Description of Pandoraea gen. nov. with Pandoraea apista sp. nov., Pandoraea pulmonicola sp. nov., Pandoraea pnomenusa sp. nov., Pandoraea sputorum sp. nov. and Pandoraea norimbergensis comb. nov. Int J Syst Evol Microbiol (2000) 2.20
Actinomyces europaeus sp. nov., isolated from human clinical specimens. Int J Syst Bacteriol (1997) 2.17
Identification of Campylobacter cinaedi isolated from blood and feces of children and adult females. J Clin Microbiol (1990) 2.10
Public health. The cholera crisis in Africa. Science (2009) 2.02
Characteristics of antibiotic-resistant Escherichia coli in the rectum of healthy school-children. J Med Microbiol (1977) 1.87
Phenotypic and phylogenetic characterization of some Globicatella-like organisms from human sources: description of Facklamia hominis gen. nov., sp. nov. Int J Syst Bacteriol (1997) 1.82
Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis. Arthritis Rheum (1998) 1.79
A placebo-controlled trial of a pertussis-toxoid vaccine. N Engl J Med (1995) 1.78
Bordetella trematum sp. nov., isolated from wounds and ear infections in humans, and reassessment of Alcaligenes denitrificans Rüger and Tan 1983. Int J Syst Bacteriol (1996) 1.76
Role of interferon during viremia. II. Protective action of circulating interferon. J Immunol (1966) 1.76
Treatment of toxoplasmosis with trimethoprim-sulphamethoxazole. Scand J Infect Dis (1975) 1.74
Burkholderia fungorum sp. nov. and Burkholderia caledonica sp. nov., two new species isolated from the environment, animals and human clinical samples. Int J Syst Evol Microbiol (2001) 1.73
Emended description of Herbaspirillum; inclusion of [Pseudomonas] rubrisubalbicans, a milk plant pathogen, as Herbaspirillum rubrisubalbicans comb. nov.; and classification of a group of clinical isolates (EF group 1) as Herbaspirillum species 3. Int J Syst Bacteriol (1996) 1.73
Evaluation of PCR for diagnosis of Bordetella pertussis and Bordetella parapertussis infections. J Clin Microbiol (1998) 1.68
Characterization of a novel Atopobium isolate from the human vagina: description of Atopobium vaginae sp. nov. Int J Syst Bacteriol (1999) 1.64
Assignment of Centers for Disease Control group IVc-2 to the genus Ralstonia as Ralstonia paucula sp. nov. Int J Syst Bacteriol (1999) 1.64
Ornithobacterium rhinotracheale gen. nov., sp. nov., isolated from the avian respiratory tract. Int J Syst Bacteriol (1994) 1.58
Parapertussis infection followed by pertussis infection. Lancet (1994) 1.49
Actinomyces graevenitzii sp. nov., isolated from human clinical specimens. Int J Syst Bacteriol (1997) 1.49
Penetration of newer cephalosporins into cerebrospinal fluid. Rev Infect Dis (1989) 1.49
Bacteremia after liver biopsy. Arch Intern Med (1973) 1.49
Helcococcus ovis sp. nov., a gram-positive organism from sheep. Int J Syst Bacteriol (1999) 1.46
Clinical and pharmacokinetic studies on cefuroxime. J Antimicrob Chemother (1977) 1.45
Characterization of some strains from human clinical sources which resemble "Leptotrichia sanguinegens": description of Sneathia sanguinegens sp. nov., gen. nov. Syst Appl Microbiol (2001) 1.43
Periodic fever. Diagnostic and therapeutic problems. JAMA (1974) 1.40
Characterization of Actinomyces isolates from infected root canals of teeth: description of Actinomyces radicidentis sp. nov. J Clin Microbiol (2000) 1.38
Primary identification of Microbacterium spp. encountered in clinical specimens as CDC coryneform group A-4 and A-5 bacteria. J Clin Microbiol (1995) 1.38
Clostridium difficile in relation to enteric bacterial pathogens. J Clin Microbiol (1980) 1.36
Description of Gemella sanguinis sp. nov., isolated from human clinical specimens. J Clin Microbiol (1998) 1.35
Dysgonomonas gen. nov. to accommodate Dysgonomonas gadei sp. nov., an organism isolated from a human gall bladder, and Dysgonomonas capnocytophagoides (formerly CDC group DF-3). Int J Syst Evol Microbiol (2000) 1.34
Corynebacterium kroppenstedtii sp. nov., a novel corynebacterium that does not contain mycolic acids. Int J Syst Bacteriol (1998) 1.34
A review of the penetration of antibiotics into CSF and its clinical significance. Scand J Infect Dis Suppl (1978) 1.33
Case of apparent reinfection with rubella. Lancet (1970) 1.31
The 1970 epidemic of diphtheria in San Antonio. Ann Intern Med (1971) 1.31
Gemella bergeriae sp. nov., isolated from human clinical specimens. J Clin Microbiol (1998) 1.30
Interactions between Toxoplasma gondii and its host cells: function of the penetration-enhancing factor of toxoplasma. Infect Immun (1975) 1.28
Factors enhancing the host-cell penetration of Toxoplasma gondii. J Bacteriol (1967) 1.27
Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens. J Infect Dis (1991) 1.27
Facklamia ignava sp. nov., isolated from human clinical specimens. J Clin Microbiol (1998) 1.26
Lysosomes of Toxoplasma gondii and their possible relation to the host-cell penetration of toxoplasma parasites. J Bacteriol (1968) 1.23
Neisseria weaveri sp. nov. (formerly CDC group M-5), from dog bite wounds of humans. Int J Syst Bacteriol (1993) 1.22
Reclassification of Bacteroides ureolyticus as Campylobacter ureolyticus comb. nov., and emended description of the genus Campylobacter. Int J Syst Evol Microbiol (2009) 1.21
Acidovorax, a new genus for Pseudomonas facilis, Pseudomonas delafieldii, E. Falsen (EF) group 13, EF group 16, and several clinical isolates, with the species Acidovorax facilis comb. nov., Acidovorax delafieldii comb. nov., and Acidovorax temperans sp. nov. Int J Syst Bacteriol (1990) 1.21
Classification of Pseudomonas diminuta Leifson and Hugh 1954 and Pseudomonas vesicularis Büsing, Döll, and Freytag 1953 in Brevundimonas gen. nov. as Brevundimonas diminuta comb. nov. and Brevundimonas vesicularis comb. nov., respectively. Int J Syst Bacteriol (1994) 1.21
Effect of hemodialysis and renal failure on serum and urine concentrations of cephapirin sodium. Antimicrob Agents Chemother (1972) 1.17
Characterization of Actinomyces isolates from samples from the human urogenital tract: description of Actinomyces urogenitalis sp. nov. Int J Syst Evol Microbiol (2000) 1.15
Molecular epidemiology of the 1984-1986 outbreak of diphtheria in Sweden. N Engl J Med (1988) 1.14
Polyphasic taxonomic approach in the description of Alishewanella fetalis gen. nov., sp. nov., isolated from a human foetus. Int J Syst Evol Microbiol (2000) 1.13
Comparison between agar and broth minimum inhibitory concentrations of cefamandole, Cefoxitin, and cefuroxime. Antimicrob Agents Chemother (1979) 1.12
Kingella kingae infections: a review and a presentation of data from 10 Swedish cases. Scand J Infect Dis (1985) 1.11
Penetration-enhancing factor extracted from Toxoplasma gondii which increases its virulence for mice. J Bacteriol (1968) 1.11
PCR for detection and identification of Abiotrophia spp. J Clin Microbiol (1998) 1.08
Inhibition of immunoreactive tumor necrosis factor-alpha by a chimeric antibody in patients infected with human immunodeficiency virus type 1. J Infect Dis (1996) 1.08
Efficacy of a monocomponent pertussis toxoid vaccine after household exposure to pertussis. J Pediatr (1997) 1.08
In vitro comparison of N-formimidoyl thienamycin, piperacillin, cefotaxime, and cefoperazone. Antimicrob Agents Chemother (1981) 1.07
Characterization of Lyme borreliosis isolates from patients with erythema migrans and neuroborreliosis in southern Sweden. J Clin Microbiol (2001) 1.07
Characterization of a Rothia-like organism from a mouse: description of Rothia nasimurium sp. nov. and reclassification of Stomatococcus mucilaginosus as Rothia mucilaginosa comb. nov. Int J Syst Evol Microbiol (2000) 1.07
Characterization of Actinomyces turicensis and Actinomyces radingae strains from human clinical samples. Int J Syst Bacteriol (1998) 1.07
Susceptibility of Bordetella pertussis to doxycycline, cinoxacin, nalidixic acid, norfloxacin, imipenem, mecillinam and rifampicin. J Antimicrob Chemother (1985) 1.06
Hydrotalea flava gen. nov., sp. nov., a new member of the phylum Bacteroidetes and allocation of the genera Chitinophaga, Sediminibacterium, Lacibacter, Flavihumibacter, Flavisolibacter, Niabella, Niastella, Segetibacter, Parasegetibacter, Terrimonas, Ferruginibacter, Filimonas and Hydrotalea to the family Chitinophagaceae fam. nov. Int J Syst Evol Microbiol (2010) 1.06
Environmental contamination leading to false-positive polymerase chain reaction for pertussis. Pediatr Infect Dis J (1994) 1.06
Facklamia sourekii sp. nov., isolated from human sources. Int J Syst Bacteriol (1999) 1.04
Facklamia languida sp. nov., isolated from human clinical specimens. J Clin Microbiol (1999) 1.04
Results of a clinical trial of cefoxitin, a new cephamycin antibiotic. Antimicrob Agents Chemother (1977) 1.04
Serotypes and clinical manifestations of group B streptococcal infections in western Sweden. Clin Microbiol Infect (2000) 1.04
Enzyme sensitisation in consumers of enzyme-containing washing powder. Lancet (1970) 1.04
Polyphasic approach to the classification and identification of Gardnerella vaginalis and unidentified Gardnerella vaginalis-like coryneforms present in bacterial vaginosis. Int J Syst Bacteriol (1996) 1.03
Microbial growth and accumulation in industrial metal-working fluids. Appl Environ Microbiol (1989) 1.02
Abiotrophia balaenopterae sp. nov., isolated from the minke whale (Balaenoptera acutorostrata). Int J Syst Bacteriol (1999) 1.02
Cytotoxin production in 100 strains of Haemophilus ducreyi from different geographic locations. FEMS Microbiol Lett (1995) 1.02
Corynebacterium testudinoris sp. nov., from a tortoise, and Corynebacterium felinum sp. nov., from a Scottish wild cat. Int J Syst Evol Microbiol (2001) 1.01
In-vitro antibacterial activity of SQ 26,776. J Antimicrob Chemother (1981) 1.01
Bacteria Are Omnipresent on Phanerochaete chrysosporium Burdsall. Appl Environ Microbiol (1996) 1.00
Facklamia tabacinasalis sp. nov., from powdered tobacco. Int J Syst Bacteriol (1999) 1.00
Aerococcus christensenii sp. nov., from the human vagina. Int J Syst Bacteriol (1999) 0.99
Scarlet fever and necrotizing fascitis caused by coagulase-positive hemolytic Staphylococcus aureus, phage type 85. Ann Intern Med (1973) 0.99
Endocarditis caused by Erysipelothrix insidiosa. Am J Clin Pathol (1973) 0.99
Quantitative nephrotoxicity of gentamicin in nontoxic doses. J Infect Dis (1980) 0.99
Pharmacokinetic and clinical studies on cefuroxime. Proc R Soc Med (1977) 0.98
Mass vaccination of children with pertussis toxoid--decreased incidence in both vaccinated and nonvaccinated persons. Clin Infect Dis (2001) 0.98
Actinomyces naeslundii genospecies 1 and 2 express different binding specificities to N-acetyl-beta-D-galactosamine, whereas Actinomyces odontolyticus expresses a different binding specificity in colonizing the human mouth. Oral Microbiol Immunol (1998) 0.97
Biochemical identification of Citrobacter species defined by DNA hybridization and description of Citrobacter gillenii sp. nov. (formerly Citrobacter genomospecies 10) and Citrobacter murliniae sp. nov. (formerly Citrobacter genomospecies 11). J Clin Microbiol (1999) 0.97
[Resistance determination of bacteria: new classification in sensitive groups--S, I and R]. Lakartidningen (1978) 0.97
Characteristics of Arthrobacter cumminsii, the most frequently encountered Arthrobacter species in human clinical specimens. J Clin Microbiol (1998) 0.97
Role of interferon during viremia. I. Production of circulating interferon. J Immunol (1966) 0.97
Vagococcus lutrae sp. nov., isolated from the common otter (Lutra lutra). Int J Syst Bacteriol (1999) 0.97
Whole-cell protein electrophoretic analysis of viridans streptococci: evidence for heterogeneity among Streptococcus mitis biovars. Int J Syst Bacteriol (1998) 0.96
Ignavigranum ruoffiae sp. nov., isolated from human clinical specimens. Int J Syst Bacteriol (1999) 0.96
Characterization of a Gemella-like organism from the oral cavity of a dog: description of Gemella palaticanis sp. nov. Int J Syst Bacteriol (1999) 0.95